Page last updated: 2024-12-05

2-fluoroadenine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-fluoroadenine is a synthetic nucleoside analog that has been investigated for its potential therapeutic applications. It exhibits antiviral, anti-inflammatory, and anticancer activities. 2-fluoroadenine is synthesized through a multi-step process involving the fluorination of adenine. Its antiviral properties stem from its ability to inhibit viral DNA polymerase, thereby preventing viral replication. The anti-inflammatory effects of 2-fluoroadenine are attributed to its suppression of the production of pro-inflammatory cytokines. In cancer therapy, 2-fluoroadenine has been shown to induce apoptosis and inhibit cell proliferation in various cancer cell lines. Furthermore, 2-fluoroadenine has been investigated as a potential radio-sensitizer, enhancing the efficacy of radiation therapy. Extensive research is ongoing to explore the potential of 2-fluoroadenine as a safe and effective therapeutic agent in various diseases.'

2-fluoroadenine : An organofluorine compound that is adenine in which the hydrogen at position 2 (the carbon between the two nitrogens of the pyrimidine ring) is replaced by a fluorine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12790
CHEMBL ID580404
CHEBI ID72457
SCHEMBL ID8850
MeSH IDM0115129

Synonyms (61)

Synonym
AC-15593
2c8h3h4ebg ,
unii-2c8h3h4ebg
9h-adenine, 2-fluoro-
adenine, 2-fluoro-
2-fluoroadenine
nsc-27364
sri 774
nsc27364
purine, 6-amino-2-fluoro-
1h-purin-6-amine, 2-fluoro-
2-fluoro-6-aminopurine ,
700-49-2
2-fad
adenine, 2-fluoro- (van)
brn 0610958
2-fluoro-1h-purin-6-amine
nsc 27364
inchi=1/c5h4fn5/c6-5-10-3(7)2-4(11-5)9-1-8-2/h1h,(h3,7,8,9,10,11
2-fluoroadenine, 96%
A2F ,
6-amino-2-fluoropurine
F0647
TCMDC-124283 ,
2-fluoro-7h-purin-6-amine
chebi:72457 ,
CHEMBL580404
AKOS005063499
A836748
2-fluoro-7h-purin-6-amine;2-fluoroadenine
AKOS005257768
2-fluoro-7(9)h-purin-6-ylamine
AKOS006223977
f-ade
2-fluoro-9h-purin-6-amine
FT-0612403
c5h4fn5
STL454963
SCHEMBL8850
MB08365
9h-purin-6-amine, 2-fluoro
fludarabine phosphate impurity, 2-fluoroadenine- [usp impurity]
fludarabine phosphate impurity d [ep impurity]
fluoroadenine
WKMPTBDYDNUJLF-UHFFFAOYSA-N
DTXSID80220264
PS-6414
CS-W008469
2-fluoro-9h-purin-6-amine, aldrichcpr
BBL102193
STL555992
BCP20080
Q27139933
SY036850
mfcd01632749
AM9918
EN300-697497
HY-W008469
2-fluoro-7h-purin-6-amine (2-fluoroadenine)
PD131035
Z1198269560
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organofluorine compoundAn organofluorine compound is a compound containing at least one carbon-fluorine bond.
purinesA class of imidazopyrimidines that consists of purine and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1159588Biochemical screen of P. falciparum CDPK42016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159585Biochemical screen of P. falciparum CDPK12016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159586Biochemical screen of P. falciparum PK62016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159589Biochemical screen of P. falciparum MAPK22016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159587Biochemical screen of P. falciparum PK72016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1065714Trypanocidal activity against bloodstream stage of Trypanosoma brucei brucei AnTat1.1E after 72 hrs by WST-1 assay2013Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.
AID1452128Inhibition of ATPgammaS-BODIPY binding to Thermotoga maritima His-tagged HK853 expressed in Escherichia coli BL21(DE3)pLysS Rosetta preincubated for 30 mins prior to ATPgammaS-BODIPY addition measured after 1 hr by coomassie staining-based SDS-PAGE analys2017Journal of medicinal chemistry, 10-12, Volume: 60, Issue:19
Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases.
AID1065710Displacement of [2,8-3H]-adenosine from Trypanosoma brucei AT1/P2 expressed in bloodstream stage of Trypanosoma brucei brucei B482013Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (21.74)18.7374
1990's1 (4.35)18.2507
2000's10 (43.48)29.6817
2010's7 (30.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.86 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index27.81 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]